A JAK2-V617F activating mutation in addition to KIT and FLT3 mutations is associated with clinical outcome in patients with t(8;21)(q22;q22) acute myeloid leukemia

Gardado en:
Detalles Bibliográficos
Main Authors: Iwanaga, Eisaku, Nanri, Tomoko, Matsuno, Naofumi, Kawakita, Toshiro, Mitsuya, Hiroaki, Asou, Norio
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2009
Assuntos:
Acute Myeloid Leukemia
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2649368/
https://ncbi.nlm.nih.gov/pubmed/19181784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.13283
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares